FRIDAY, Feb. 11, 2022 (HealthDay News) -- Open-label placebo (OLP) may have a beneficial effect for the treatment of functional abdominal pain or irritable bowel syndrome in children and adolescents, according to a study published online Jan. 31 in JAMA…
